Goldman Sachs’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-157,592
| Closed | -$728K | – | 5501 |
|
|
2019
Q1 | $728K | Buy |
157,592
+10,688
| +7% | +$50.6K | ﹤0.01% | 4232 |
|
|
2018
Q4 | $514K | Sell |
146,904
-722
| -0.5% | -$5.02K | ﹤0.01% | 4347 |
|
|
2018
Q3 | $1.49M | Buy |
147,626
+3,432
| +2% | +$27.4K | ﹤0.01% | 3791 |
|
|
2018
Q2 | $1.04M | Buy |
144,194
+27,241
| +23% | +$190K | ﹤0.01% | 4040 |
|
|
2018
Q1 | $706K | Sell |
116,953
-723
| -0.6% | -$5.97K | ﹤0.01% | 4270 |
|
|
2017
Q4 | $1.13M | Sell |
117,676
-16,163
| -12% | -$106K | ﹤0.01% | 4239 |
|
|
2017
Q3 | $1.19M | Sell |
133,839
-3,614
| -3% | -$37.3K | ﹤0.01% | 4431 |
|
|
2017
Q2 | $1.74M | Sell |
137,453
-89,115
| -39% | -$1.05M | ﹤0.01% | 3950 |
|
|
2017
Q1 | $2.38M | Sell |
226,568
-39,168
| -15% | -$417K | ﹤0.01% | 3573 |
|
|
2016
Q4 | $2.44M | Buy |
265,736
+78,476
| +42% | +$887K | ﹤0.01% | 3669 |
|
|
2016
Q3 | $2.21M | Sell |
187,260
-466,877
| -71% | -$7.1M | ﹤0.01% | 3745 |
|
|
2016
Q2 | $8.46M | Buy |
654,137
+408,606
| +166% | +$5.96M | ﹤0.01% | 2443 |
|
|
2016
Q1 | $3.93M | Sell |
245,531
-119,503
| -33% | -$2.27M | ﹤0.01% | 2901 |
|
|
2015
Q4 | $10.5M | Sell |
365,034
-349,812
| -49% | -$9.69M | ﹤0.01% | 2217 |
|
|
2015
Q3 | $20.3M | Buy |
714,846
+644,557
| +917% | +$23.7M | 0.01% | 1699 |
|
|
2015
Q2 | $2.52M | Buy |
70,289
+33,893
| +93% | +$1.06M | ﹤0.01% | 3607 |
|
|
2015
Q1 | $1.06M | Sell |
36,396
-91,186
| -71% | -$2.41M | ﹤0.01% | 4411 |
|
|
2014
Q4 | $2.69M | Sell |
127,582
-212,144
| -62% | -$4.19M | ﹤0.01% | 3549 |
|
|
2014
Q3 | $6.59M | Buy |
339,726
+62,864
| +23% | +$987K | ﹤0.01% | 2746 |
|
|
2014
Q2 | $4.32M | Buy |
276,862
+197,980
| +251% | +$3.2M | ﹤0.01% | 3209 |
|
|
2014
Q1 | $1.63M | Sell |
78,882
-456
| -0.6% | -$9.04K | ﹤0.01% | 4157 |
|
|
2013
Q4 | $1.02M | Buy |
+79,338
| New | +$1.1M | ﹤0.01% | 4729 |
|
Other funds holding INSY
WS
Goldman Sachs's INSY Position: Q2 2019 in Review
Goldman Sachs sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 157,592 shares — an estimated $728K sold.
Goldman Sachs first reported a position in INSY in Q4 2013 and held it in 22 quarters. The position peaked at $20.3M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Goldman Sachs reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Goldman Sachs sold 157,592 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $728K.
- Goldman Sachs first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 22 quarters.
- Goldman Sachs's Insys Therapeutics, Inc. position peaked at $20.3M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Goldman Sachs's 13F filing for Q2 2019, filed 14 Aug 2019.